SAIDAL · SAI

SAIDAL is an Algerian pharmaceutical group focused on the development, production, and marketing of medicines and healthcare products. The company is one of the country's best-known domestic drug manufacturers and operates in a sector shaped by public health needs, medicine security, local production capacity, regulatory oversight, and demand from pharmacies, hospitals, wholesalers, and public health institutions. SAIDAL's activities cover pharmaceutical manufacturing, product development, quality control, commercialization, and participation in Algeria's wider strategy to strengthen domestic healthcare supply chains. Its portfolio orientation gives investors exposure to recurring demand for essential medicines, but performance is also influenced by regulated pricing, procurement dynamics, manufacturing efficiency, product mix, raw-material availability, and compliance with pharmaceutical standards. As a listed company on the Algiers Stock Exchange, SAIDAL provides a direct route to Algeria's pharmaceutical industry and local medicine production base. Its business profile is distinct from pure distributors because it is tied to industrial capability, production assets, regulatory approvals, and the ability to supply the domestic market reliably.